Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership
Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape
Johnson & Johnson Soars: Beating Q3 Expectations and Raising Full-Year Outlook
Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs
Wall Street Reacts: Top Stock Moves and Analyst Insights Shaping Thursday's Market
A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review
Unleash the Alpha: Why This October Dog of the Dow is a Top Dividend Pick
Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks
Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals
Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs
IG Acquisition Corp. (IGAC): The Power of a Vanishing Discount Fueling Stellar Returns
Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule
Nanobiotix Shares Explode on Game-Changing Melanoma Data, Supercharging J&J Partnership Outlook
Healthcare Shorts Take a Breather, But Moderna Remains Under the Microscope
Kenvue Explores 'Learned Intermediary' Defense Amidst Thousands of Tylenol-Autism Lawsuits
Controversial Critic Returns: Dr. Vinay Prasad Reassumes Key FDA Role
A New Horizon in Bladder Cancer Treatment: J&J's Balversa Secures Full FDA Approval
Game Changer: FDA Approves Johnson & Johnson's TAR-200 for High-Risk Bladder Cancer
Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave
Legend Biotech Explores Strategic Second Listing Beyond US Shores
Amneal Pharmaceuticals Secures Landmark FDA Approval for Generic Risperdal Consta
Carlsmed's Personalized Spine Implants Revolutionize Care with Landmark Reimbursement Approval
First RSV shots, groundbreaking gene therapy among 2024 drugs to watch